A novel, noninvasive brain stimulation approach—known as transcranial temporal interference stimulation (TIs)—may offer a new ...

When my husband, Bruce Willis, was diagnosed with frontotemporal dementia (FTD), our family was thrust into a world we were ...

The deal gives Cellular Intelligence control of a clinical-stage therapy designed to restore the dopamine-producing nerve ...

The startup, Cellular Intelligence, is gaining rights to the early-stage treatment and will be in charge of shepherding it ...

PD, a shelved Parkinson's cell therapy, to AI biotech Cellular Intelligence in return for equity and milestones.

Last October, Novo Nordisk had shut down its cell therapy unit as part of a broader restructuring, discontinuing development ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

Meta CEO Mark Zuckerberg backed-Cellular Intelligence has acquired Danish drugmaker Novo Nordisk's cell therapy candidate for ...

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

The Health, Labor and Welfare Ministry will consider whether to cover a medicine derived from induced pluripotent stem cells for the treatment of Parkinson’s disease under the public health insurance ...

Essential tremor is a common neurological condition that causes shaking, especially during movement, and is often mistaken ...

Parkinson’s disease is a long-term brain condition that mainly affects movement and physical control. It develops slowly over ...